Celiac disease in Iran: a systematic review and meta-analysis

Introduction: Celiac disease (CD) is a chronic autoimmune-mediated disorder with both intestinal and systemic manifestations. The aim of this study was to determine the prevalence of celiac disease in Iran. Methods: We conducted a systematic search on Embase, Pub Med, Web of Science, Google Schola...

Full description

Bibliographic Details
Main Authors: Roghayeh Mohammadibakhsh, Rahim Sohrabi, Morteza Salemi, Masood Taheri Mirghaed, Masoud Behzadifar
Format: Article
Language:English
Published: Electronic Physician 2017-03-01
Series:Electronic Physician
Subjects:
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407219/
id doaj-ff8e078a268648c5b78e7ee6f8dec906
record_format Article
spelling doaj-ff8e078a268648c5b78e7ee6f8dec9062020-11-24T22:06:43ZengElectronic PhysicianElectronic Physician2008-58422008-58422017-03-01933883389510.19082/3883Celiac disease in Iran: a systematic review and meta-analysisRoghayeh MohammadibakhshRahim Sohrabi,Morteza Salemi,Masood Taheri MirghaedMasoud BehzadifarIntroduction: Celiac disease (CD) is a chronic autoimmune-mediated disorder with both intestinal and systemic manifestations. The aim of this study was to determine the prevalence of celiac disease in Iran. Methods: We conducted a systematic search on Embase, Pub Med, Web of Science, Google Scholar, MagIran, Scientific Information database (SID) and Iranmedex from 2003 through to November 2015. The Der-Simonian/ Laird’s (DL), with a 95% confidence interval employed to estimate the overall pooled prevalence. Heterogeneity was investigated by using subgroup analysis based on sample size and time of study. Results: Sixty-three studies with 36,833 participants met inclusion criteria for analysis. The overall prevalence of celiac disease in 63 studies that had used serological tests for the diagnosis was observed as 3% (95% CI: 0.03- 0.03) and the overall prevalence of celiac disease in studies that had used biopsy method for diagnosis was observed as 2% (95% CI: 0.01- 0.02). Conclusion: The prevalence of celiac disease in Iran was similar or even higher than world-wide reportedhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407219/PrevalenceMeta-analysisCeliac diseaseIran
collection DOAJ
language English
format Article
sources DOAJ
author Roghayeh Mohammadibakhsh
Rahim Sohrabi,
Morteza Salemi,
Masood Taheri Mirghaed
Masoud Behzadifar
spellingShingle Roghayeh Mohammadibakhsh
Rahim Sohrabi,
Morteza Salemi,
Masood Taheri Mirghaed
Masoud Behzadifar
Celiac disease in Iran: a systematic review and meta-analysis
Electronic Physician
Prevalence
Meta-analysis
Celiac disease
Iran
author_facet Roghayeh Mohammadibakhsh
Rahim Sohrabi,
Morteza Salemi,
Masood Taheri Mirghaed
Masoud Behzadifar
author_sort Roghayeh Mohammadibakhsh
title Celiac disease in Iran: a systematic review and meta-analysis
title_short Celiac disease in Iran: a systematic review and meta-analysis
title_full Celiac disease in Iran: a systematic review and meta-analysis
title_fullStr Celiac disease in Iran: a systematic review and meta-analysis
title_full_unstemmed Celiac disease in Iran: a systematic review and meta-analysis
title_sort celiac disease in iran: a systematic review and meta-analysis
publisher Electronic Physician
series Electronic Physician
issn 2008-5842
2008-5842
publishDate 2017-03-01
description Introduction: Celiac disease (CD) is a chronic autoimmune-mediated disorder with both intestinal and systemic manifestations. The aim of this study was to determine the prevalence of celiac disease in Iran. Methods: We conducted a systematic search on Embase, Pub Med, Web of Science, Google Scholar, MagIran, Scientific Information database (SID) and Iranmedex from 2003 through to November 2015. The Der-Simonian/ Laird’s (DL), with a 95% confidence interval employed to estimate the overall pooled prevalence. Heterogeneity was investigated by using subgroup analysis based on sample size and time of study. Results: Sixty-three studies with 36,833 participants met inclusion criteria for analysis. The overall prevalence of celiac disease in 63 studies that had used serological tests for the diagnosis was observed as 3% (95% CI: 0.03- 0.03) and the overall prevalence of celiac disease in studies that had used biopsy method for diagnosis was observed as 2% (95% CI: 0.01- 0.02). Conclusion: The prevalence of celiac disease in Iran was similar or even higher than world-wide reported
topic Prevalence
Meta-analysis
Celiac disease
Iran
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407219/
work_keys_str_mv AT roghayehmohammadibakhsh celiacdiseaseiniranasystematicreviewandmetaanalysis
AT rahimsohrabi celiacdiseaseiniranasystematicreviewandmetaanalysis
AT mortezasalemi celiacdiseaseiniranasystematicreviewandmetaanalysis
AT masoodtaherimirghaed celiacdiseaseiniranasystematicreviewandmetaanalysis
AT masoudbehzadifar celiacdiseaseiniranasystematicreviewandmetaanalysis
_version_ 1725822239795838976